MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Development of a nanoherbaceutical formulation containing compound extracts from huperzia serrata, mucuna pruriens and withania somnifera for the prevention and treatment of Parkinson’s disease

    V. Kumar, P.C. Bhatt (Allahabad, India)

    Objective: We developed the nanoherbaceutical formulation and evaluated against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced Parkinson's disease (PD) model. Background: PD is a progressive neurodegenerative disorder allied…
  • 2016 International Congress

    Effect of repeated intravenous amantadine infusions in patients with Parkinson’s disease

    A. Khlebtovsky, I. Steiner, R. Djaldetti, T. Treves (Petach Tikva, Israel)

    Objective: To examine the long-term effect of repeated boosts of intravenous amantadine in patients with PD with and without response fluctuations and dyskinesias. Background: Amantadine…
  • 2016 International Congress

    A national case study of virtual care visits for Parkinson’s disease (RACE-PD): Interim assessment of participant and investigator experiences

    R. Korn, H.T. Keenan, T. Felong, S. Goldenthal, S. Kanchana, H. Schwarz, S. Sharma, K. Andrzejewski, E.A. Stevenson, R. Barbano, G. Kang, K. Rizer, A. Shukla, M.J. Dodge, C. Tanner, M. Katz, R. Rodriguez, N. Galifianakis, W. Zhu (Rochester, NY, USA)

    Objective: RACE-PD is a case series that aims to assess the feasibility and utility of a national program providing individuals with Parkinson's disease (PD) a…
  • 2016 International Congress

    Effectivity and safety of rotigotine transdermal patch on motor and cognitive dysfunctions in Parkinson’s disease with dementia and dementia with Lewy bodies

    K. Ohta, Y. Kujuro, T. Osada, T. Toguchi, Y. Shinohara (Tokyo, Japan)

    Objective: This study aimed to demonstrate effectivity and safety of rotigotine transdermal patch (RTP) on motor and cognitive dysfunctions in patients with Parkinson's disease with…
  • 2016 International Congress

    Association of the DRD2 (CA) n and DRD3 Ser9Gly polymorphisms with Parkinson’s disease and response of dopamine agonists

    S. Xu, J. Liu, X. Yang, Y. Qian, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate the association between dopamine receptor D types 2(DRD2) (CA)n and types 3 (DRD3) Ser9Gly polymorphisms and the risk of Parkinson's disease (PD),…
  • 2016 International Congress

    Medicinal cannabis for Parkinson’s disease: A survey of practices, beliefs, and attitudes among providers at NPF centers of excellence

    D. Bega, T. Simuni, M.S. Okun, P. Schmidt (Chicago, IL, USA)

    Objective: To gather data on the cannabis-related prescribing practices, and views regarding potential risks and benefits of cannabis, among experts caring for patients with PD.…
  • 2016 International Congress

    Validity and reliability of the test d evaluation des membres superieurs de personnes agees (TEMPA) to assess upper limb in Parkinson’s disease

    C.L. Correa, P.R. de-Freitas, A.E. Lemos, S.M. Michaelsen, A. Swarowsky (Rio de Janeiro, Brazil)

    Objective: This study aims to carry out validity and reliability of the Test dEvaluation des Membres Superieurs Des Personnes Agees (TEMPA) in patients with PD.…
  • 2016 International Congress

    Does distance walked after two minutes predict total 6 minute walk test distance in people with Parkinson’s disease?

    R.P. Duncan, M.E. McNeely, G.M. Earhart (Saint Louis, MO, USA)

    Objective: To determine if the distance walked in the first two minutes of the 6 Minute Walk Test (6MWT) accurately predicts the total distance walked…
  • 2016 International Congress

    Balance training in individual’s with Parkinson’s disease: Therapist-supervised vs. home-based exercise programmes

    E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)

    Objective: To evaluate and compare the efficacy of a home-based balance programme to therapist-supervised programme on gait parameters, dynamic balance, balance confidence and motivation in…
  • 2016 International Congress

    Eight weeks of home-based balance training not as effective as therapist-based during dual tasks

    E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)

    Objective: To assess the effect of balance training on dual-tasking gait, and to investigate if a home-based programme is comparable to a therapist-supervised programme. Background:…
  • « Previous Page
  • 1
  • …
  • 1527
  • 1528
  • 1529
  • 1530
  • 1531
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Safety and Tolerability of a Ketone Supplement in Parkinson's Disease
  • Successful external defibrillation in a patient with bilateral deep brain stimulation
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley